Adekola P, Ugwu F, Amoo E, Olawole-Isaac A, Cirella G
Front Public Health. 2023; 10:935625.
PMID: 36699940
PMC: 9868670.
DOI: 10.3389/fpubh.2022.935625.
Ocal S
Clin Respir J. 2021; 16(1):13-16.
PMID: 34674363
PMC: 8653083.
DOI: 10.1111/crj.13455.
Kim S, Kim J, Noh S, Sohn H, Lee T
Biochip J. 2020; 14(4):327-339.
PMID: 33224441
PMC: 7670017.
DOI: 10.1007/s13206-020-4401-2.
Siemens N, Oehmcke-Hecht S, Mettenleiter T, Kreikemeyer B, Valentin-Weigand P, Hammerschmidt S
Front Microbiol. 2018; 8:2602.
PMID: 29312268
PMC: 5742597.
DOI: 10.3389/fmicb.2017.02602.
Grantz K, Rane M, Salje H, Glass G, Schachterle S, Cummings D
Proc Natl Acad Sci U S A. 2017; 114(18):E3588-E3589.
PMID: 28386047
PMC: 5422798.
DOI: 10.1073/pnas.1703851114.
Secondary bacterial infections in influenza virus infection pathogenesis.
Smith A, McCullers J
Curr Top Microbiol Immunol. 2014; 385:327-56.
PMID: 25027822
PMC: 7122299.
DOI: 10.1007/82_2014_394.
The co-pathogenesis of influenza viruses with bacteria in the lung.
McCullers J
Nat Rev Microbiol. 2014; 12(4):252-62.
PMID: 24590244
DOI: 10.1038/nrmicro3231.
Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
Gilmer D, Schmitz J, Euler C, Fischetti V
Antimicrob Agents Chemother. 2013; 57(6):2743-50.
PMID: 23571534
PMC: 3716137.
DOI: 10.1128/AAC.02526-12.
A geographic analysis of population density thresholds in the influenza pandemic of 1918-19.
Chandra S, Kassens-Noor E, Kuljanin G, Vertalka J
Int J Health Geogr. 2013; 12:9.
PMID: 23425498
PMC: 3641965.
DOI: 10.1186/1476-072X-12-9.
Exploiting what phage have evolved to control gram-positive pathogens.
Fischetti V
Bacteriophage. 2012; 1(4):188-194.
PMID: 23050211
PMC: 3448103.
DOI: 10.4161/bact.1.4.17747.
Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis.
Wu M, Lin C, Huang S, Shih H, Wang C, Lee C
Influenza Other Respir Viruses. 2012; 7(3):349-55.
PMID: 22672284
PMC: 5779838.
DOI: 10.1111/j.1750-2659.2012.00386.x.
The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions.
Chien Y, Levin B, Klugman K
PLoS One. 2012; 7(1):e29219.
PMID: 22291887
PMC: 3264555.
DOI: 10.1371/journal.pone.0029219.
Pandemic influenza: certain uncertainties.
Morens D, Taubenberger J
Rev Med Virol. 2011; 21(5):262-84.
PMID: 21706672
PMC: 3246071.
DOI: 10.1002/rmv.689.
Influenza virus primes mice for pneumonia from Staphylococcus aureus.
Iverson A, Boyd K, McAuley J, Plano L, Hart M, McCullers J
J Infect Dis. 2011; 203(6):880-8.
PMID: 21278211
PMC: 3071123.
DOI: 10.1093/infdis/jiq113.
Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.
Fischetti V
Int J Med Microbiol. 2010; 300(6):357-62.
PMID: 20452280
PMC: 3666336.
DOI: 10.1016/j.ijmm.2010.04.002.
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
Daniel A, Euler C, Collin M, Chahales P, Gorelick K, Fischetti V
Antimicrob Agents Chemother. 2010; 54(4):1603-12.
PMID: 20086153
PMC: 2849374.
DOI: 10.1128/AAC.01625-09.
A mouse model of lethal synergism between influenza virus and Haemophilus influenzae.
Ni Lee L, Dias P, Han D, Yoon S, Shea A, Zakharov V
Am J Pathol. 2010; 176(2):800-11.
PMID: 20042666
PMC: 2808086.
DOI: 10.2353/ajpath.2010.090596.
Understanding influenza transmission, immunity and pandemic threats.
Mathews J, Chesson J, McCaw J, McVernon J
Influenza Other Respir Viruses. 2009; 3(4):143-9.
PMID: 19627371
PMC: 4634682.
DOI: 10.1111/j.1750-2659.2009.00089.x.
